Re-Stenosis after Successful Coronary Angioplasty

New England Journal of Medicine

Volumn 318, Issue 26, 1988, Pages 1734-1737

  Mcbride, Wade ^a   Lange, Richard A ^a   Hillis, L David ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DILATATION; HUMAN; ISCHEMIC HEART DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; STENOSIS; THEORETICAL STUDY;

ANGIOPLASTY, BALLOON; ANIMAL; CORONARY DISEASE; HUMAN; RECURRENCE;

EID: 0023904401     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198806303182606     Document Type: Article

References (85)

1. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results, and patterns of re-Stenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987; 13: 1–15.
2. Bentivoglio LG. Immediate and long-term results of percutaneous coronary angioplasty. Herz 1985; 10: 275–80.
3. Ernst SMPG, van der Feltz TA, Bai ET, et al. Long term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J 1987; 57: 220–5.
4. Holmes DR Jr, Vlietstra RE, Smith HC, et al. re-Stenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: Suppl: 77C–81C.
5. Leimgruber PP, Roubin GS, Hollman J, et al. re-Stenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986; 73: 710–7.
6. Levine S, Ewels CJ, Rosing DR, Kent KM. Coronary angioplasty: clinical and angiographic follow-up. Am J Cardiol 1985; 55: 673–6.
7. Guiteras Val P, Bourassa MG, David PR, et al. re-Stenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. Am J Cardiol 1987; 60: Suppl: 50B–55B.
8. Dervan JP, Bairn DS, Cherniles J, Grossman W. Transluminal angioplasty of occluded coronary arteries: use of a movable guide wire system. Circulation 1983; 68: 776–84.
9. Melchior JP, Meier B, Urban P, et al. Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. Am J Cardiol 1987; 59: 535–8.
10. Pasternak RC, Baughman KL, Fallón JT, Block PC. Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol 1980; 45: 591–8.
11. Zollikofer CL, Salomonowitz E, Sibley R, et al. Transluminal angioplasty evaluated by electron microscopy. Radiology 1984; 153: 369–74.
12. Block PC, Baughman KL, Pasternak RC, Fallón JT. Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation 1980; 61: 778–85.
13. Faxon DP, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis 1982; 2: 125–33.
14. Sanborn TA, Faxon DP, Haudenschild C, Gottsman SB, Ryan TJ. The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis. Circulation 1983; 68: 1136–40.
15. Castaneda-Zuniga WR, Formanek A, Tadavarthy M, et al. The mechanism of balloon angioplasty. Radiology 1980; 135: 565–71.
16. Lyon RT, Zarins CK, Lu C-T, Yang C-F, Glagov S. Vessel, plaque, and lumen morphology after transluminal balloon angioplasty: quantitative study in distended human arteries. Arteriosclerosis 1987; 7: 306–14.
17. Baughman KL, Pasternak RC. Fallón JT, Block PC. Transluminal coronary angioplasty of postmortem human hearts. Am J Cardiol 1981; 48: 1044–7.
18. Block PC, Myler RK, Stertzer S, Fallón JT. Morphology after transluminal angioplasty in human beings. N Engl J Med 1981; 305: 382–5.
19. Kohchi K, Takebayashi S, Block PC, Hiroki T, Nobuyoshi M. Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy. J Am Coll Cardiol 1987; 10: 592–9.
20. Soward AL, Essed CE, Serruys PW. Coronary arterial findings after accidental death immediately after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1985; 56: 794–5.
21. Mizuno K, Kurita A, Imazeki N. Pathological findings after percutaneous transluminal coronary angioplasty. Br Heart J 1984; 52: 588–90.
22. Holmes DR Jr, Vlietstra RE, Mock MB, et al. Angiographic changes produced by percutaneous transluminal coronary angioplasty. Am J Cardiol 1983; 51: 676–83.
23. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976; 295: 369–77.
24. Ross. The pathogenesis of atherosclerosis. N Engl J Med 1976; 295: 420–5.
25. Ross R. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 314: 488–500.
26. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105–12.
27. Faxon DP, Sanborn TA, Weber VJ, et al. re-Stenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 1984; 4: 189–95.
28. Essed CE, van den Brand M, Becker AE. Transluminal coronary angioplasty and early re-Stenosis: fibrocellular occlusion after wall laceration. Br Heart J 1983; 49: 393–6.
29. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6: 369–75.
30. Waller BF, Pinkerton CA, Foster LN. Morphologic evidence of accelerated left main coronary artery stenosis: a late complication of percutaneous transluminal balloon angioplasty of the proximal left anterior descending coronary artery. J Am Coll Cardiol 1987; 9: 1019–23.
31. Bruneval P, Guermonprez JL, Perrier P, Carpentier A, Camilleri JP. Coronary artery re-Stenosis following transluminal coronary angioplasty. Arch Pathol Lab Med 1986; 110: 1186–7.
32. Lam JY, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V. Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 1986; 8: 1380–6.
33. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987; 75: 636–42.
34. Faxon DP, Sanborn TA, Haudenschild CC, Ryan TJ. Effect of antiplatelet therapy on re-Stenosis after experimental angioplasty. Am J Cardiol 1984; 53: Suppl: 72C–76C.
35. Gordon JB, Berk BC, Bettmann MA, Selwyn AP, Rennke H, Alexander RW. Vascular smooth muscle proliferation following balloon injury is synergistically inhibited by low molecular weight heparin and hydrocortisone. Circulation 1987; 76: Suppl IV: IV–213. abstract.
36. Kaltenbach M, Kober G, Scherer D, Vallbracht C. Recurrence rate after successful coronary angioplasty. Eur Heart J 1985; 6: 276–81.
37. Rupprecht HJ, Brennecke R, Erbel R, et al. Early and long-term outcome after PTCA in stable versus unstable angina. J Am Coll Cardiol 1987; 9: Suppl: 150A. abstract.
38. Leisch F, Schützenberger W, Kerschner K, Herbinger W. Influence of a variant angina on the results of percutaneous transluminal coronary angioplasty. Br Heart J 1986; 56: 341–5.
39. Willerson JT, Hillis LD, Winniford M, Buja LM. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol 1986; 8: 245–50.
40. Vandormael MG, Deligonul U, Kern MJ, et al. Multilesion coronary angioplasty: clinical and angiographic follow-up. J Am Coll Cardiol 1987; 10: 246–52.
41. Galan KM, Hollman JL. Recurrence of stenoses after coronary angioplasty. Heart Lung 1986; 15: 585–7.
42. Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation 1985; 71: 90–7.
43. Hodgson JM, Reinert S, Most AS, Williams DO. Prediction of long-term clinical outcome with final translesional pressure gradient during coronary angioplasty. Circulation 1986; 74: 563–6.
44. Hirshfeld JW Jr, MacDonald R, Goldberg S, et al. Patient-related variables predictive of re-Stenosis after PTCA — a report from the M-HEART study. Circulation 1987; 76: Suppl IV: IV–214. abstract.
45. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985; 6: 1239–44.
46. Roubin GS, King SB III, Douglas JS Jr. re-Stenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. Am J Cardiol 1987; 60: Suppl: B: 39–43B.
47. DiSciascio G, Cowley MJ, Vetrovec GW. Angiographic patterns of re-Stenosis after angioplasty of multiple coronary arteries. Am J Cardiol 1986; 58: 922–5.
48. Leimgruber PP, Roubin GS, Anderson HV, et al. Influence of intimal dissection on re-Stenosis after successful coronary angioplasty. Circulation 1985; 72: 530–5.
49. Simpfendorfer C, Belardi J, Bellamy G, Galan K, Franco I, Hollman J. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 59: 267–9.
50. Hirshfeld JW Jr, Goldberg S, MacDonald R, et al. Lesion and procedure-related variables predictive of re-Stenosis after PTCA — a report from the M-HEART study. Circulation 1987; 76: Suppl IV: IV–215. abstract.
51. Roubin GS, Hutchison N, Douglas JS Jr, King SB III. Influence of balloon size on complications and late re-Stenosis after coronary angioplasty: a prospective randomized trial. Circulation 1987; 76: Suppl IV: IV–215. abstract.
52. Swanson KT, Vlietstra RE, Holmes DR Jr, et al. Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty. Am J Cardiol 1984; 54: 447–8.
53. White CW, Chaitman B, Lassar TA, et al. Antiplatelet agents are effective in reducing the immediate complications of PTCA: results from the Ticlopidine Multicenter Trial. Circulation 1987; 76: Suppl IV: IV–400. abstract.
54. Barnathan ES, Schwartz JS, Taylor L, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 1987; 76: 125–34.
55. Schwartz L, Bourassa MG, Lespérance J, et al. Aspirin and dipyridamole in the prevention of re-Stenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714–9.
56. White CW, Knudson M, Schmidt D, et al. Neither ticlopidine nor aspirin-dipyridamole prevents re-Stenosis post PTCA: results from a randomized placebo-controlled multicenter trial. Circulation 1987; 76: Suppl IV: IV–213. abstract.
57. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin: in vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 1980; 46: 625–34.
58. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986; 58: 839–45.
59. Clowes. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest 1985; 52: 611–6.
60. Ellis SG, Roubin GS, Wilentz J, Lin S, Douglas JS Jr, King SB III. Results of a randomized trial of heparin and aspirin vs. aspirin alone for prevention of acute closure (achéal) and re-Stenosis (R) after angioplasty (PTCA). Circulation 1987; 76: Suppl IV: IV–213. abstract.
61. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69: 721–7.
62. Faxon DP, Sandborn TA, Haudenschild CC, Gottsman SB, Ryan TJ. The effect of nifedipine on re-Stenosis following experimental angioplasty. Circulation 1984; 70: Suppl II: II–175. abstract.
63. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986; 8: 1271–6.
64. Corcos T, David PR, Guiteras Val P, et al. Failure of diltiazem to prevent re-Stenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985; 109: 926–31.
65. MacDonald RG, Panush RS, Pepine CJ. Rationale for use of glucocorticoids in modification of re-Stenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 60: Suppl: 56B–60B.
66. Grigg LE, Kay T, Manolas EG, Hunt D, Valentine PA. Does max-EPA lower the risk of re-Stenosis after PTCA: a prospective randomized trial. Circulation 1987; 76: Suppl IV: IV–214. abstract.
67. Dehmer GJ, van den Berg EK, Popma JJ, Prewitt JP, Willerson JT, Schmitz JM. Dietary supplementation with N–3 fatty acids reduces the rate of re-Stenosis after coronary angioplasty. J Am Coll Cardiol 1988; 11: 237A. abstract.
68. Dotter CT, Buschmann RW, McKinney MK, Rösch J. Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology 1983; 147: 259–60.
69. Cragg A, Lund G, Rysavy J, Castaneda F, Castaneda-Zuniga W, Amplatz K. Nonsurgical placement of arterial endoprostheses: a new technique using nitinol wire. Radiology 1983; 147: 261–3.
70. Palmaz JC, Windeler SA, Garcia F, Tio FO, Sibbitt RR, Reuter SR. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology 1986; 160: 723–6.
71. Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon-expandable intracoronary stents in the adult dog. Circulation 1987; 76: 450–7.
72. Roubin GS, Robinson KA, King SB III, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation 1987; 76: 891–7.
73. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and re-Stenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701–6.
74. Sigwart U, Imbert C, Essinger A, Fischer A, Sadeghi H, Kappenberger L. One year of percutaneous coronary stenting (PTCS). Circulation 1987; 76: Suppl IV: IV–26. abstract.
75. Puel J, Rousseau H, Joffre F, Hatem S, Fauvel JM, Bounhoure JP. Intravascular stents to prevent re-Stenosis after transluminal coronary angioplasty. Circulation 1987; 76: Suppl IV: IV–27. abstract.
76. Choy DSJ, Stertzer S, Rotterdam HZ, Sharrock N, Kaminow IP. Transluminal laser catheter angioplasty. Am J Cardiol 1982; 50: 1206–8.
77. Abela GS, Normann SJ, Cohen DM, et al. Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro. Circulation 1985; 71: 403–11.
78. Crea F, Fenech A, Smith W, Conti CR, Abela GS. Laser recanalization of acutely thrombosed coronary arteries in live dogs: early results. J Am Coll Cardiol 1985; 6: 1052–6.
79. Ginsburg R, Wexler L, Mitchell RS, Profitt D. Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Radiology 1985; 156: 619–24.
80. Cumberland DC, Sanborn TA, Tayler DI, et al. Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet 1986; 1: 1457–9.
81. Cumberland DC, Starkey IR, Oakley GDG, et al. Percutaneous laser-assisted coronary angioplasty. Lancet 1986; 2: 214.
82. Crea F, Davies G, McKenna W, Pashazade M, Taylor K, Maseri A. Percutaneous laser recanalization of coronary arteries. Lancet 1986; 2: 214–5.
83. Sanborn TA, Faxon DP, Kellett MA, Ryan TJ. Percutaneous coronary laser thermal angioplasty. J Am Coll Cardiol 1986; 8: 1437–40.
84. Sanborn TA, Haudenschild CC, Garber GR, Ryan TJ, Faxon DP. Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty. Circulation 1987; 75: 1281–6.
85. Spears JR. Percutaneous transluminal coronary angioplasty re-Stenosis: potential prevention with laser balloon angioplasty. Am J Cardiol 1987; 60: Suppl: 61B–64B.